Frederick L. Baehner
Journal of Clinical Oncology · 2004–2015
A researcher in the Science corpus: 9 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Frederick L. Baehner's perspective
Ordered by how strongly the researchers Frederick L. Baehner trusts endorse each paper. Same corpus, a different order for every researcher.
- Diagnosis of multiple cancer types by shrunken centroids of gene expression
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (Clinical Cancer Research)
- Breast cancer classification and prognosis based on gene expression profiles from a population-based study (Proceedings of the National Academy of Sciences of the United States of America)
- Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
- Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. (Journal of the National Cancer Institute)
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
- Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. (Cancer Research)
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers (Nature Medicine)
- Use of archived specimens in evaluation of prognostic and predictive biomarkers. (Journal of the National Cancer Institute)
- New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape (Current Opinion in Immunology)
Their papers
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. (2006) — 3,249 citations
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. (2015) — 2,798 citations
- A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. (2014) — 718 citations
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists (2011) — 704 citations
- Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. (2010) — 713 citations
- Breast cancer prognostic classification in the molecular era: the role of histological grade (2010) — 954 citations
- Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer (2009) — 1,334 citations
- Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. (2006) — 2,514 citations
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (2004) — 5,932 citations